WeVote
Log In

Bill

Bill

SF 3786

Epilepsy-related prescription drugs and medical supplies cost sharing limitation provision

2025-2026 Regular Session Introduced by Jim Abeler and 1 co-sponsor

Minnesota bill caps patient cost-sharing for epilepsy medications and medical supplies to improve medication access and reduce seizure risks from cost-driven non-compliance.

Referred to Commerce and Consumer Protection
#commerceandcommercedepartment #healthandhealthdepartment #insurance-health
0
WeVote Research Nonpartisan
Bill Summary · SF 3786

Legislative bill overview

SF 3786 limits cost-sharing requirements (copayments, coinsurance, and deductibles) for epilepsy-related prescription drugs and medical supplies in Minnesota. The bill ensures that individuals with epilepsy have more affordable access to necessary medications and equipment by capping out-of-pocket expenses. This applies to health insurance plans regulated by the state.

Why is this important

Epilepsy medications are often expensive and must be taken consistently to prevent seizures, making cost barriers potentially dangerous. High out-of-pocket costs can force patients to skip doses or forgo necessary supplies, increasing seizure risk and emergency room visits. This bill addresses a documented access problem for a chronic condition affecting approximately 150,000 Minnesotans.

Potential points of contention

  • Insurance premium impact: Limiting cost-sharing may increase baseline insurance premiums for all customers if insurers shift costs, potentially affecting those without epilepsy
  • Definition scope: The bill's specificity regarding which drugs and supplies qualify as "epilepsy-related" could create disputes between insurers and patients over coverage
  • Applicability limits: The bill may only apply to state-regulated plans, leaving federal employees and self-insured employer plans outside its protections, creating coverage gaps

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.